Tuberculosis and Respiratory Diseases

  • 제78권3호
  • /
  • Pages.276-280
  • /
  • 2015
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

A Case of Pulmonary Cryptococcosis in an Immunocompetent Male Patient Diagnosed by a Percutaneous Supraclavicular Lymph Node Biopsy

  • Sung, Ji Hee (Department of Internal Medicine, Bundang Jesaeng General Hospital) ;
  • Kim, Do Hoon (Department of Internal Medicine, Bundang Jesaeng General Hospital) ;
  • Oh, Mi-Jung (Department of Internal Medicine, Bundang Jesaeng General Hospital) ;
  • Lee, Kyoung Ju (Department of Internal Medicine, Bundang Jesaeng General Hospital) ;
  • Bae, Young A (Department of Radiology, Bundang Jesaeng General Hospital) ;
  • Kwon, Kye Won (Department of Pathology, Bundang Jesaeng General Hospital) ;
  • Lee, Seung Min (Department of Internal Medicine, Bundang Jesaeng General Hospital) ;
  • Kang, Ho Joon (Department of Internal Medicine, Bundang Jesaeng General Hospital) ;
  • Choi, Jinyoung (Department of Internal Medicine, Bundang Jesaeng General Hospital)
  • 투고 : 2014.08.27
  • 심사 : 2015.01.07
  • 발행 : 2015.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Cryptococcal pneumonia usually occurs in immunocompromised patients with malignancy, acquired immune deficiency syndrome, organ transplantations, immunosuppressive chemotherapies, catheter insertion, or dialysis. It can be diagnosed by gaining tissues in lung parenchyma or detecting antigen in blood or bronchoalveolar lavage fluid. Here we report an immunocompetent 32-year-old male patient with diabetes mellitus diagnosed with cryptococcal pneumonia after a ultrasound-guided percutaneous supraclavicular lymph node core needle biopsy. We treated him with fluconazole at 400 mg/day for 9 months according to the guideline. This is the first case that cryptococcal pneumonia was diagnosed from a percutaneous lymph node biopsy in South Korea.

키워드

참고문헌

  1. Chang WC, Tzao C, Hsu HH, Lee SC, Huang KL, Tung HJ, et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 2006;129:333-40. https://doi.org/10.1378/chest.129.2.333
  2. Nadrous HF, Antonios VS, Terrell CL, Ryu JH. Pulmonary cryptococcosis in nonimmunocompromised patients. Chest 2003;124:2143-7. https://doi.org/10.1016/S0012-3692(15)31671-8
  3. Nakamura S, Miyazaki Y, Higashiyama Y, Yanagihara K, Ohno H, Hirakata Y, et al. Community acquired pneumonia (CAP) caused by Cryptococcus neoformans in a healthy individual. Scand J Infect Dis 2005;37:932-5. https://doi.org/10.1080/00365540410025195
  4. Chang YS, Chou KC, Wang PC, Yang HB, Chen CH. Primary pulmonary cryptococcosis presenting as endobronchial tumor with left upper lobe collapse. J Chin Med Assoc 2005;68:33-6. https://doi.org/10.1016/S1726-4901(09)70129-7
  5. Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology 2012;17:913-26. https://doi.org/10.1111/j.1440-1843.2012.02150.x
  6. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010;50:291-322. https://doi.org/10.1086/649858
  7. Huang L, Crothers K. HIV-associated opportunistic pneumonias. Respirology 2009;14:474-85. https://doi.org/10.1111/j.1440-1843.2009.01534.x
  8. Johannson KA, Huston SM, Mody CH, Davidson W. Cryptococcus gattii pneumonia. CMAJ 2012;184:1387-90. https://doi.org/10.1503/cmaj.111346
  9. Thomas CJ, Lee JY, Conn LA, Bradley ME, Gillespie RW, Dill SR, et al. Surveillance of cryptococcosis in Alabama, 1992-1994. Ann Epidemiol 1998;8:212-6. https://doi.org/10.1016/S1047-2797(97)00234-2
  10. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-8. https://doi.org/10.1086/313757
  11. Fox DL, Muller NL. Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol 2005;185:622-6. https://doi.org/10.2214/ajr.185.3.01850622
  12. Lindell RM, Hartman TE, Nadrous HF, Ryu JH. Pulmonary cryptococcosis: CT findings in immunocompetent patients. Radiology 2005;236:326-31. https://doi.org/10.1148/radiol.2361040460
  13. Hung MS, Tsai YH, Lee CH, Yang CT. Pulmonary cryptococcosis: clinical, radiographical and serological markers of dissemination. Respirology 2008;13:247-51. https://doi.org/10.1111/j.1440-1843.2007.01202.x
  14. Guy JP, Raza S, Bondi E, Rosen Y, Kim DS, Berger BJ. Cryptococcus pneumonia presenting in an immunocompetent host with pulmonary asbestosis: a case report. J Med Case Rep 2012;6:170. https://doi.org/10.1186/1752-1947-6-170

피인용 문헌

  1. Intra-cavitary pulmonary cryptococcoma in poorly controlled diabetes mellitus vol.28, pp.None, 2015, https://doi.org/10.1016/j.mmcr.2020.02.005
  2. Pulmonary cryptococcosis presenting as miliary tuberculosis in an immunocompetent patient vol.9, pp.1, 2015, https://doi.org/10.4103/jacp.jacp_5_20
  3. Cryptococcosis complicating diabetes mellitus: a scoping review vol.8, pp.None, 2015, https://doi.org/10.1177/20499361211014769